Cigna Ends Humira Coverage
This is a Cigna news story, published by Yahoo, that relates primarily to AbbVie news.
Cigna news
For more Cigna news, you can click here:
more Cigna newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo news
For more news from Yahoo, you can click here:
more news from YahooAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
blockbuster rheumatoid arthritis drug Humira. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest biggest selling prescription medicine news, Humira biosimilars news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
pharmacy benefits unit Express ScriptsReuters
•Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
79% Informative
Cigna will remove AbbVie ’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025 .
Pharmacy benefit managers have come under increased scrutiny from U.S. agencies and lawmakers this year for their alleged role in keeping drug prices high.
VR Score
89
Informative language
96
Neutral language
48
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links